October 23, 2014
October 23, 2014 —
In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the California Institute for Regenerative Medicine, the state’s stem cell agency.
November 21, 2022
November 21, 2022 —
UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.
June 6, 2019
June 6, 2019 —
…his lab at the Sanford Consortium for Regenerative Medicine UCTV Launches New Stem Cell Channel Viewers to go behind the scenes from autism to zebrafish Alysson R. Muotri loves stem cells. He runs a lab that studies them, and he’s inspired by the fascinating work colleagues around him are doing.…
February 2, 2015
February 2, 2015 —
The governing board of the California Institute for Regenerative Medicine (CIRM) has awarded two University of California, San Diego researchers almost $3 million in combined funding to pursue new technologies intended to accelerate advances moving stem cell therapies out of the lab and into the clinic.
October 30, 2014
October 30, 2014 —
…Coming of Age of Stem Cell Therapy Photos by Erik Jepsen/UC San Diego Publications With first clinical trials, UC San Diego pushes stem cell therapies into a new era of real-world application In 2004, the therapeutic potential of stem cells persuaded more than 7 million Californians to approve Proposition 71,…
November 22, 2022
November 22, 2022 —
The UC San Diego Sanford Stem Cell Institute leads its first space launch, sending stem cells into space aboard the International Space Station. The NASA-partnered study will take advantage of the microgravity environment of space to study accelerated aging in stem cells.
July 20, 2018
July 20, 2018 —
…of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
August 11, 2014
August 11, 2014 —
Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This Phase I clinical trial is recruiting eight patients for the 5-year study.
March 17, 2016
March 17, 2016 —
…of California, Davis to pursue a novel human embryonic stem cell-based therapy to rescue and restore neurons devastated by amyotrophic lateral sclerosis or ALS.
June 1, 2018
June 1, 2018 —
Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.